Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
The FDA is adding International Organization for Standardization (ISO) guidelines to its “good manufacturing” requirements
Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.
Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas
Recent efforts to forecast the next infectious disease outbreak and steps labs can take to ensure they’re prepared.